KKR is still interested in buying Depomed, which has been up for sale, according to press reports. Final bids for Depomed, an opioid maker, are due Wednesday, the New York Post is reporting. Daichi Sankyo, of Japan, is also expected to bid, the story said. Depomed, of Newark, California, acquired Nucynta in early 2015 from Janssen Pharmaceuticals Inc for just over $1 billion, Reuters has reported.
READ FULL ARTICLE HERE
David S. Brown Enterprises has bolstered its Retail Leasing team with the recent hiring of Michael Gosnell
The Virginia law firm Gentry Locke is pleased to announce the promotion of Scott A. Stephenson to
Pessin Katz Law is pleased to announce that Attorney Adam E. Konstas has been elected to Member
Skanska, a leading global construction and development firm, announces that Gary Orton has joined the company as
For partnerships, content marketing or advertising inquiries, please contact Edwin through his LinkedIn Profile
Connect© Copyright 2024 citybuzz
